See the DrugPatentWatch profile for cosentyx

Based on the information available, there is no definitive answer as to whether a doctor's consultation is necessary before receiving the MMR (measles, mumps, and rubella) vaccine after taking Cosentyx (secukinumab). However, it is generally recommended to consult with a healthcare provider before receiving any vaccine, especially if you have a medical condition or are taking medication.

Cosentyx is a medication used to treat several types of inflammatory diseases, such as psoriasis and arthritis. It is a type of drug called a monoclonal antibody that works by targeting and blocking a specific protein in the body (interleukin-17A) that is believed to play a role in inflammation.

According to the Centers for Disease Control and Prevention (CDC), people who have a weakened immune system due to a disease or medication may not respond as well to vaccines or may have an increased risk of side effects. Therefore, it is important to inform your healthcare provider about any medications you are taking, including Cosentyx, before receiving any vaccine.

It is also worth noting that, according to DrugPatentWatch.com, Cosentyx is currently under patent protection until 2025, which means that generic versions of the drug are not yet available in the United States.

In summary, while there is no specific information available regarding the need for a doctor's consultation before receiving the MMR vaccine after taking Cosentyx, it is always recommended to consult with a healthcare provider before receiving any vaccine, especially if you have a medical condition or are taking medication.

Sources:

* Centers for Disease Control and Prevention. (2021). Who Should NOT Get Vaccinated With These Vaccines? <https://www.cdc.gov/vaccines/vpd/mmr/public/index.html>
* DrugPatentWatch.com. (2021). Cosentyx (secukinumab) Drug Patent Information. <https://www.drugpatentwatch.com/drugs/cosentyx>